Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Anti-MDA5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.

Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi YO, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K.

Br J Dermatol. 2016 Jul 25. doi: 10.1111/bjd.14882. [Epub ahead of print]

PMID:
27452897
2.

Latent pathogenicity of the G38S polymorphism of KCNE1 K+ channel modulator.

Yamaguchi Y, Mizumaki K, Hata Y, Sakamoto T, Nakatani Y, Kataoka N, Ichida F, Inoue H, Nishida N.

Heart Vessels. 2016 Jun 2. [Epub ahead of print]

PMID:
27255646
3.

Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.

Kataoka N, Nishida K, Kinoshita K, Sakamoto T, Nakatani Y, Tsujino Y, Mizumaki K, Inoue H, Kinugawa K.

Heart Vessels. 2016 Dec;31(12):2053-2060.

PMID:
27236656
4.

Paced QRS fragmentation is associated with spontaneous ventricular fibrillation in patients with Brugada syndrome.

Kataoka N, Mizumaki K, Nakatani Y, Sakamoto T, Yamaguchi Y, Tsujino Y, Nishida K, Inoue H.

Heart Rhythm. 2016 Jul;13(7):1497-503. doi: 10.1016/j.hrthm.2016.03.050.

PMID:
27018377
5.

Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study.

Hata Y, Kinoshita K, Mizumaki K, Yamaguchi Y, Hirono K, Ichida F, Takasaki A, Mori H, Nishida N.

Heart Rhythm. 2016 Jul;13(7):1544-51. doi: 10.1016/j.hrthm.2016.03.038.

PMID:
27005929
6.

SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.

Kinoshita K, Takahashi H, Hata Y, Nishide K, Kato M, Fujita H, Yoshida S, Murai K, Mizumaki K, Nishida K, Yamaguchi Y, Kano M, Tabata T, Nishida N.

Heart Rhythm. 2016 May;13(5):1113-20. doi: 10.1016/j.hrthm.2016.01.008.

PMID:
26776555
7.

Coefficient of Variation of P-Wave Duration Is a Novel Atrial Heterogeneity Index to Predict Recurrence of Atrial Fibrillation After Catheter Ablation.

Nakatani Y, Sakamoto T, Mizumaki K, Nishida K, Kataoka N, Tsujino Y, Yamaguchi Y, Inoue H.

J Cardiovasc Electrophysiol. 2016 May;27(5):542-8. doi: 10.1111/jce.12920.

PMID:
26756553
8.

Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy.

Yamaguchi Y, Mizumaki K, Iwamoto J, Nishida K, Sakamoto T, Nakatani Y, Kataoka N, Inoue H.

J Arrhythm. 2015 Dec;31(6):391-4. doi: 10.1016/j.joa.2015.04.006.

9.

Differentiation of Slow-Slow Form of AVNRT from AVRT through a Posteroseptal Accessory Pathway by Retrograde P-Wave Amplitude.

Nakatani Y, Mizumaki K, Sakamoto T, Kataoka N, Nishida K, Yamaguchi Y, Tsujino Y, Inoue H.

Pacing Clin Electrophysiol. 2016 Mar;39(3):241-9. doi: 10.1111/pace.12794.

PMID:
26643980
10.

Abnormal repolarization dynamics in a patient with KCNE1(G38S) who presented with torsades de pointes.

Yamaguchi Y, Mizumaki K, Hata Y, Inoue H.

J Electrocardiol. 2016 Jan-Feb;49(1):94-8. doi: 10.1016/j.jelectrocard.2015.10.002.

PMID:
26520166
11.

Time-Dependent Changes in QT Dynamics after Initiation and Termination of Paroxysmal Atrial Fibrillation.

Yamaguchi Y, Mizumaki K, Nishida K, Sakamoto T, Kataoka N, Nakatani Y, Inoue H.

Pacing Clin Electrophysiol. 2015 Dec;38(12):1418-24. doi: 10.1111/pace.12746.

PMID:
26391623
12.

Promising toxicological biomarkers for the diagnosis of liver injury types: Bile acid metabolic profiles and oxidative stress marker as screening tools in drug development.

Masubuchi N, Nishiya T, Imaoka M, Mizumaki K, Okazaki O.

Chem Biol Interact. 2016 Aug 5;255:74-82. doi: 10.1016/j.cbi.2015.09.012.

PMID:
26365562
13.

Bepridil enhances aprindine-induced prolongation of atrial effective refractory period in a canine atrial rapid pacing model.

Nakatani Y, Sakamoto T, Nishida K, Kataoka N, Yamaguchi Y, Sakabe M, Fujiki A, Mizumaki K, Inoue H.

J Cardiol. 2015 Nov;66(5):445-50. doi: 10.1016/j.jjcc.2015.06.001.

14.

Glycine/Serine polymorphism at position 38 influences KCNE1 subunit's modulatory actions on rapid and slow delayed rectifier K+ currents.

Yamaguchi Y, Nishide K, Kato M, Hata Y, Mizumaki K, Kinoshita K, Nonobe Y, Tabata T, Sakamoto T, Kataoka N, Nakatani Y, Ichida F, Mori H, Fukurotani K, Inoue H, Nishida N.

Circ J. 2014;78(3):610-8.

15.

Characterization of a novel mutant KCNQ1 channel subunit lacking a large part of the C-terminal domain.

Kimoto K, Kinoshita K, Yokoyama T, Hata Y, Komatsu T, Tsushima E, Nishide K, Yamaguchi Y, Mizumaki K, Tabata T, Inoue H, Nishida N, Fukurotani K.

Biochem Biophys Res Commun. 2013 Oct 18;440(2):283-8. doi: 10.1016/j.bbrc.2013.09.075.

PMID:
24070608
16.

Electrophysiological and anatomical differences of the slow pathway between the fast-slow form and slow-slow form of atrioventricular nodal reentrant tachycardia.

Nakatani Y, Mizumaki K, Nishida K, Sakamoto T, Yamaguchi Y, Kataoka N, Sakabe M, Fujiki A, Inoue H.

Europace. 2014 Apr;16(4):551-7. doi: 10.1093/europace/eut253.

17.

Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.

Nakatani Y, Nishida K, Sakabe M, Kataoka N, Sakamoto T, Yamaguchi Y, Iwamoto J, Mizumaki K, Fujiki A, Inoue H.

J Am Coll Cardiol. 2013 Feb 5;61(5):582-8. doi: 10.1016/j.jacc.2012.11.014. Erratum in: J Am Coll Cardiol. 2013 Dec 10;62(23):2260.

18.

Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.

Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M; J-ROCKET AF study investigators..

Circ J. 2012;76(9):2104-11.

19.

Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.

Sakabe M, Fujiki A, Sakamoto T, Nakatani Y, Mizumaki K, Inoue H.

J Cardiovasc Electrophysiol. 2012 Oct;23(10):1130-5. doi: 10.1111/j.1540-8167.2012.02356.x.

PMID:
22587612
20.

Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients.

Nakatani Y, Mizumaki K, Nishida K, Hirai T, Sakabe M, Oda Y, Joho S, Fujiki A, Nozawa T, Inoue H.

Circ J. 2012;76(2):317-21.

Items per page

Supplemental Content

Loading ...
Support Center